ng-nitroarginine methyl ester has been researched along with Cardiomyopathy, Congestive in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dumont, L; Fontaine, E; Jasmin, G; Tanguay, M; Véronneau, M | 1 |
| Arai, Y; Egashira, K; Katsuda, Y; Shimokawa, H; Tada, H; Takeshita, A; Usui, M; Yamamoto, M | 1 |
2 other study(ies) available for ng-nitroarginine methyl ester and Cardiomyopathy, Congestive
| Article | Year |
|---|---|
Reactivity to endothelium-dependent and -independent vasoactive substances is maintained in coronary resistance vessels of the failing hamster heart.
Topics: Acetylcholine; Animals; Cardiomyopathy, Dilated; Chronic Disease; Coronary Vessels; Cricetinae; Cyclooxygenase Inhibitors; Endothelium, Vascular; Indomethacin; Mesocricetus; Models, Biological; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitroprusside; Perfusion; Potassium Channels; Tetraethylammonium Compounds; Vasodilator Agents | 1997 |
Role of nitric oxide in regulation of coronary blood flow in response to increased metabolic demand in dogs with pacing-induced heart failure.
Topics: Animals; Cardiomyopathy, Dilated; Coronary Circulation; Coronary Vessels; Disease Models, Animal; Dogs; Energy Metabolism; Enzyme Inhibitors; Heart Failure; Hemodynamics; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroarginine; Pacemaker, Artificial; Vasodilation | 2001 |